Search research articles
Contact Us
Filters
Showing results (131-140 of 174) with videos related to
Page
of 18
Sort By:
Expert Review of Clinical Immunology
|
May 5, 2026
What is the best way to plan a 12-months clinical drug trial in JIA associated uveitis
Ivan Foeldvari, Ameenat Solebo, Sheila T Angeles-Han, et al.
Annals of the Rheumatic Diseases
|
August 12, 2022
Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial
Hermine I Brunner, Ivan Foeldvari, Ekaterina Alexeeva, et al.
Arthritis Research & Therapy
|
October 25, 2011
Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features
Rudolf Mierau, Pia Moinzadeh, Gabriela Riemekasten, et al.
Journal of Scleroderma and Related Disorders
|
March 26, 2019
An Interim Report of the Scleroderma Clinical Trials Consortium Working Groups
Murray Baron, Bashar Kahaleh, Elana J Bernstein, et al.
Annals of the Rheumatic Diseases
|
March 30, 2018
Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative
Tamas Constantin, Ivan Foeldvari, Jordi Anton, et al.
Arthritis Research & Therapy
|
May 25, 2019
Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial
Ivan Foeldvari, Tamàs Constantin, Jelena Vojinović, et al.
Annals of the Rheumatic Diseases
|
May 23, 2013
Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study
Gerd Horneff, Ruben Burgos-Vargas, Tamas Constantin, et al.
Expert Review of Clinical Immunology
|
June 5, 2026
Measuring disease activity in juvenile systemic sclerosis: a multidisciplinary consensus from the Hamburg 2024 symposium
Ivan Foeldvari, Kathryn S Torok, Jens Klotsche, et al.
Arthritis and Rheumatism
|
November 30, 2006
Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database
Giorgia Martini, Ivan Foeldvari, Ricardo Russo, et al.
Arthritis Care & Research
|
August 18, 2019
Safety and Effectiveness of Adalimumab in Patients With Polyarticular Course of Juvenile Idiopathic Arthritis: STRIVE Registry Seven-Year Interim Results
Hermine I Brunner, Kabita Nanda, Mary Toth, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 174) with videos related to
Sort By:
Page
of 18
Expert Review of Clinical Immunology
|
May 5, 2026
What is the best way to plan a 12-months clinical drug trial in JIA associated uveitis
Ivan Foeldvari, Ameenat Solebo, Sheila T Angeles-Han, et al.
Annals of the Rheumatic Diseases
|
August 12, 2022
Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial
Hermine I Brunner, Ivan Foeldvari, Ekaterina Alexeeva, et al.
Arthritis Research & Therapy
|
October 25, 2011
Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features
Rudolf Mierau, Pia Moinzadeh, Gabriela Riemekasten, et al.
Journal of Scleroderma and Related Disorders
|
March 26, 2019
An Interim Report of the Scleroderma Clinical Trials Consortium Working Groups
Murray Baron, Bashar Kahaleh, Elana J Bernstein, et al.
Annals of the Rheumatic Diseases
|
March 30, 2018
Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative
Tamas Constantin, Ivan Foeldvari, Jordi Anton, et al.
Arthritis Research & Therapy
|
May 25, 2019
Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial
Ivan Foeldvari, Tamàs Constantin, Jelena Vojinović, et al.
Annals of the Rheumatic Diseases
|
May 23, 2013
Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study
Gerd Horneff, Ruben Burgos-Vargas, Tamas Constantin, et al.
Expert Review of Clinical Immunology
|
June 5, 2026
Measuring disease activity in juvenile systemic sclerosis: a multidisciplinary consensus from the Hamburg 2024 symposium
Ivan Foeldvari, Kathryn S Torok, Jens Klotsche, et al.
Arthritis and Rheumatism
|
November 30, 2006
Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database
Giorgia Martini, Ivan Foeldvari, Ricardo Russo, et al.
Arthritis Care & Research
|
August 18, 2019
Safety and Effectiveness of Adalimumab in Patients With Polyarticular Course of Juvenile Idiopathic Arthritis: STRIVE Registry Seven-Year Interim Results
Hermine I Brunner, Kabita Nanda, Mary Toth, et al.
Page
of 18